<DOC>
	<DOCNO>NCT01144754</DOCNO>
	<brief_summary>This multi-center observational study assess addition Rituximab treatment previously untreated patient Diffuse Large B-Cell Lymphomas ( DLBCL ) enrollment period 60 month . Patients study enrol collection data observation make normal clinical practice .</brief_summary>
	<brief_title>Observational Study Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Previously untreated patient DLBCL breast . Patients must CD20 positive tumor . Stage IE IIE . Must least one objective measurable evaluable disease . Baseline measurement evaluation must obtain within 4 week registration study . Patients must historical radiographic evidence CNS metastasis include previously treat , resect asymptomatic brain lesion leptomeningeal involvement . Patients must ECOG performance status 02 . Patients must adequate organ function evidence follow laboratory study ( within 2 week prior registration ) : Creatinine Clearance &gt; = 50 ml/min Total bilirubin &lt; = 2.0 mg/dl AST &lt; = 2 x upper limit normal . If document hepatic involvement lymphoma , total bilirubin &lt; = 3 x *ULN , AST &lt; = 5 x ULN . Absolute neutrophil count &gt; = 1500/mm3 platelet count &gt; = 100,000/mm3 . If document bone marrow involvement lymphoma , absolute neutrophil count &gt; = 500/mm^3 platelet count &gt; = 50,000/mm^3 . Patients must age &gt; = 18 year . Women must pregnant breast feeding due potential harmful effect fetus/baby . Women childbearing potential sexually active male strongly advise use accept effective method contraception . Patients must active infection require parental antibiotic . Patients know HIV infection exclude . Patients must normal leave ventricular ejection fraction eligible .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>